Psytech Limited News Today

Beckley Psytech Limited, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, today announced that it has entered into a definitive agreement to acquire clinical-stage life science company, Eleusis Therapeutics Limited ("Eleusis") ...

Beckley Psytech Limited, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, and Ksana Health, a behavioural health company that uses technology to provide personalised insights and interventions to improve mental health care ...

Beckley Psytech announces partnership with Empatica in latest step of digital strategy, designed to deliver personalised patient care Partnership will capture behavioural and physiological signals and predictive biomarkers in Beckley Psytech’s upcoming Phase 2 clinical trialsNew digital strategy aims to i...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Beckley Psytech bolsters pipeline of next-generation psychedelic medicines with research collaboration and strengthening of relationship with Lophora ApS Beckley Psytech to collaborate with Lophora on researching New Clinical Entities (NCE’s) Broad collaboration with Lophora will further strengthen Beckle...

Press release content from Business Wire. The AP news staff was not involved in its creation.